Monographie - Tramadol hydrochloride

Utolsó frissítés :
19/11/2024

Tramadol hydrochloride

Kémiai szerkezet

Kereskedelmi név

A kereskedelmi név meghatározó jelentőségű: a készítmények összetétele országonként, előállítóként eltérő lehet

Acugesic	Malaysia
Adolonta	Spanyolország
Amadol	Egyiptom
Analgon	Peru
Anangor	Brazília
Autrestol	Mexikó
Contramal	Belgium, Franciaország, Magyarország, Olaszország, Törökország
Dalarest	Mexikó
Dolotramine	Svájc
Dolzam	Belgium
Eufindol	Chile
Fortradol	Olaszország
Fraxidol	Olaszország
Lafedol	Argentína
Liochta	Mexikó
Lumidol	Horvátország
Mabron	Thaiföld
Megadol	Chile, Mexikó
Nobligan	Dánia, Mexikó, Svédország
Paxilfar	Portugália
Poltram	Lengyelország
Prontalgin	Olaszország
Sylador	Brazília
Tadol	Szlovénia
Topalgic	Franciaország
Trabilin	Szaúd-Arábiában
Tradolan	Ausztria, Dánia, Svédország
Tradonal	Belgium, Thaiföld
Tramabene	Ausztria
Tramadoc	Németország
Tramadolor	Ausztria
Tramadura	Németország
Tramagetic	Hollandia
Tramal	Ausztria, Brazília, Dél-Afrikai Köztársaság, Finnország, Hollandia, Horvátország, Lengyelország, Németország, Portugália, Svájc, Szlovénia, Thaiföld
Tramastad	Ausztria
Tramundin	Németország
Zamadol	Nagy-Britannia
Zamudol	Franciaország
Zydol	Nagy-Britannia

Irodalom : Tramadol hydrochloride

	Type	publikáció
365	Napló	Junfeng Gu, Wengang Qin, Fuchao Chen, Zhongyuan Xia. Long-Term Stability of Tramadol and Ketamine Solutions for Patient-Controlled Analgesia Delivery. Med Sci Monit 2015 ; 21:2528-2534.
1690	Napló	Müller H-J, Berg J. Stabilitätsstudie zu tramadolhydrochlorid im PVC-infusionbeutel. Krankenhauspharmazie 1997 ; 18: 75-79.
1892	Napló	Lebrun J, Hecq JD, Vanbeckbergen D, Jalart J, Galanti LM. Effect of freezing, long-term storage and microwave thawing on the stability of tramadol in 5% dextrose infusion in polyvinyl chloride bags. Int J Pharm Compound 2004 ; 8, 2: 156-159.
1971	Napló	Azuara ML, Sanchez Y, Reyes R, Barcia E. Physical compatibility and in vivo evaluation of drug mixtures forsubcutaneous infusion to cancer patients in palliative care. Support Care Cancer 2001
2002	Napló	Abanmy NO, Zaghloul IY, Radwan MA. Compatibility of tramadol hydrochloride injection with selected drugs and solutions. Am J Health-Syst Pharm 2005 ; 62: 1299-1302.
2024	Napló	Negro S, Martin A, Azuara ML, Sanchez Y, Barcia E. Stability of tramadol and haloperidol for continuous infusion at home. J Pain Symptom Manage 2005 ; 30: 192-199.
2139	Napló	Serrurier C, Chenot ED, Vigneron J, May I, Demor? B. Assessment of injectable drug’s administration in two intensive care units and determination of potential physico-chemical incompatibilities. EJHP Science 2006 ; 12,5: 96-99.
2176	Napló	Barcia E, Martin A, Azuara ML, Sanchez Y, Negro S. Tramadol and hyoscine N-butyl bromide combined in infusion solutions: compatibility and stability. Support Care Cancer 2007 ; 15: 57-62.
2211	Napló	Negro S, Salama A, S?nchez Y, AzuaraM.L, Barcia B. Compatibility and stability of tramadol and dexamethasone in solution and its use in terminally ill patients. J Clin Pharm Ther 2007 ; 32: 441-444.
2231	Napló	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
2814	Napló	Lebitasy M, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L. Long-term stability of tramadol hydrochloride and droperidol mixture in 5% dextrose infusion polyolefin bags at 5 +/- 3°C. Ann Pharm Fr 2009 ; 67: 272-277.
3075	Napló	Balayssac D, Badaroux L, Rodier C, Sautou-Miranda V, Bazin JE, Chopineau J. Compatibility and stability of parenteral analgesic admixtures for multimodal analgesia EJHP Science 2009 ; 15, 4: 78-82.
3082	Napló	Athanasopoulos A, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L. Long-term stability of tramadol chlorhydrate and metoclopramide hydrochloride in dextrose 5% polyolefin bag at 4°C. J Oncol Pharm Practice 2009 ; 15: 195-200.
3115	Napló	Athanasopoulos A, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L. Long term stability of the hydrochloride of tramadol and alizapride in dextrose 5% polyolefin bags at 5 +/- 3°C. Ann Pharm Fr 2010 ; 68: 157-162.
3132	Napló	Negro S, Martin A, Azuara L, Sanchez Y, Barcia E. Compatibility and stability of ternary admixtures of tramadol, haloperidol, and hyoscine. J Palliat Med 2010 ; 13, 3: 273-277.
3159	Napló	Lin, T.-F., Lin, F.-S., Chou, W.-H., Yeh, Y.-C., Lin, C.-P., Fan, S.-Z., Sun, W.-Z. Compatibility and stability of binary mixtures of ketorolac tromethamine and tramadol hydrochloride injection concentrate and diluted infusion solution. Acta Anaesthesiol Taiwan 2010 ; 48, 3 : 117-121.
3296	Napló	Salmeron-Garcia A, Navas N, Martin A, Roman E, Cabeza J, Capitan-Vallvey L.F Determination of Tramadol, Metamizole, Ropivacaine, and Bupivacaine in Analgesic Mixture Samples by HPLC with DAD Detection. J Chromatographic Sci 2009 ; 47: 1-7.
3297	Napló	Salmeron-Garcia A, Lopez-Lopez E, Roma E, Cabeza J, Navas N, Capitan-Vallvey L.F. Development of an LC–DAD Method for Analysis of Dexketoprofen, Tramadol, and Haloperidol. Study of the Stability of Mixtures Used for Patient-Controlled Analgesia. Chromatographia 2008 ; 68, 9-10: 767-772.
3372	Napló	Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S. Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine. Rev Bras Anestesiol 2013 ; 63, 1: 163-166.
3521	Laboratórium	Tramadol® - Summary of Product Characteristics. Beacon Pharmaceuticals 2012
4034	Napló	Chen F-C, Fang B-X, Li P, Zheng F, Shi X-Y. Compatibility and stability of lornoxicam with morphine, tramadol or fentanyl in infusion solutions. Afr J Pharm Pharmacol 2012 ;27,6:2055-2060
4116	Napló	Chen F, Zhu J, Li B, Yuan F, Wang K. Stability of tramadol with three 5-HT3 receptor antagonists in polyolefin bags for patient-controlled delivery systems. Drug Design Dev Ther 2016 ;10:1869-1875
4521	Napló	Polo C, D’Huart E, Lesperlette G, Vigneron J, Meyer F, Demoré B. Compatibility of injectable posaconazole with drugs commonly used in a hematology care unit. Pharmaceutical Technology in Hospital Pharmacy 2020
4698	Napló	Ayari G, D'Huart E, Vigneron J, Demoré B. Y-site compatibility of intravenous medications commonly used in intensive care units : laboratory tests on 75 mixtures involving nine main drugs. Pharmaceutical Technology in Hospital Pharmacy 2022
4842	Napló	Souha H Y, Alka G, Yunmei S, Nicole E W, Sanjay G. Harmonising IV Oxycodone with Paediatric Perioperative Medications: A Compatibility Study Through Y-Type Connectors Drug Design Dev Ther 2024 Drug Design, Development

Mentions Légales